Akoya Biosciences Inc (AKYA)
2.85
-0.05
(-1.72%)
USD |
NASDAQ |
May 17, 16:00
2.85
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Cash from Operations (TTM): -51.96M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -51.96M |
December 31, 2023 | -50.90M |
September 30, 2023 | -55.32M |
June 30, 2023 | -53.74M |
March 31, 2023 | -55.32M |
December 31, 2022 | -53.50M |
September 30, 2022 | -49.34M |
Date | Value |
---|---|
June 30, 2022 | -50.57M |
March 31, 2022 | -49.60M |
December 31, 2021 | -36.07M |
September 30, 2021 | -32.36M |
June 30, 2021 | -20.71M |
March 31, 2021 | -10.29M |
December 31, 2020 | -6.843M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-55.32M
Minimum
Mar 2023
-6.843M
Maximum
Dec 2020
-41.18M
Average
-50.08M
Median
Cash from Operations (TTM) Benchmarks
Azenta Inc | 91.45M |
Harvard Bioscience Inc | 13.62M |
Standard BioTools Inc | -97.28M |
Bionano Genomics Inc | -120.90M |
Singular Genomics Systems Inc | -73.65M |